default author photo

Meng-Zhong Liu

Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China

SCHOLARLY PAPERS

2

DOWNLOADS

155

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Progression-Free Survival at 36 Months is a Reliable Surrogate for 5-Year Overall Survival for Patients Suffering From Locally Advanced Esophageal Squamous Cell Carcinoma

Number of pages: 36 Posted: 10 Feb 2022
Yu-Xian Yang, Yu-Zhen Zheng, Tian-Tian Gao, Ze-Wei Zhang, Shi-Liang Liu, Mian Xi, Meng-Zhong Liu, Jun-Ye Wang, Shu-Nan Qi, Yong Yang and Lei Zhao
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Thoracic Surgery, Sun Yat-sen University (SYSU) - Department of Radiation Oncology, Sun Yat-sen University (SYSU) - Department of Radiation Oncology, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Radiation Oncology, Fujian Medical University - Department of Radiation Oncology and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 97 (704,534)

Abstract:

Loading...

Esophageal squamous cell carcinoma, progression-free survival at 36 months, overall survival

2.

Efficacy, Safety, and Biomarkers of Toripalimab Combined with Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II Trial (EC-CRT-001)

Number of pages: 35 Posted: 22 Nov 2022
Yu-Jia Zhu, Jing Wen, Qiaoqiao Li, Lei Zhao, Shi-Liang Liu, Baoqing Chen, Yadi Yang, Sifen Wang, Yingxin Lv, Yong-Hong Hu, Meng-Zhong Liu and Mian Xi
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 58 (980,173)

Abstract:

Loading...

Esophageal squamous cell carcinoma, toripalimab, definitive chemoradiotherapy, clinical complete response, survival.